Critical role of costimulation in the activation of naive antigen- specific TCR transgenic CD8+ T cells in vitro

Journal of Immunology

Volumn 163, Issue 3, 1999, Pages 1298-1305

  Chai, Jian Guo ^a   Vendetti, Silvia ^a   Bartok, Istvan ^a   Schoendorf, Diana ^a   Takacs, Katalin ^a   Elliott, James ^a   Lechler, Robert ^a   Dyson, Julian ^a,b  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b MRC CLINICAL SCIENCES CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; B7 ANTIGEN; CD28 ANTIGEN; CD8 ANTIGEN; CD86 ANTIGEN; EPITOPE; HY ANTIGEN; T LYMPHOCYTE ANTIGEN; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ARTICLE; CELL MATURATION; CELL STIMULATION; CONTROLLED STUDY; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; T LYMPHOCYTE ACTIVATION; THYMOCYTE; TRANSGENIC MOUSE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, DIFFERENTIATION; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CLONAL ANERGY; EPITOPES, T-LYMPHOCYTE; H-Y ANTIGEN; IMMUNOCONJUGATES; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SOLUBILITY;

EID: 0033179147     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Schwartz, R. H. 1992. Costimulation of T lymphocytes: the role of CD28, CTLA-4 and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71: 1065.
2. Mueller, D. L., M. K. Jenkins, and R. H. Schwartz. 1989. Clonal expansion verus functional clonal inactivation: a costimulatory signaling pathway determines the outcome of T cell antigen receptor occupanccy. Annu. Rev. Immunol. 7:445.
3. June, C. H., J. A. Bluestone, L. M. Nadler, and C. B. Thompson. 1994. The B7 and CD28 receptor families. Immunol. Today 15:321.
4. Chambers, C. A., and J. A. Allison. 1997. Costimulation in T cells. Curr. Opin. Immunol. 9:396.
5. Lenschow, D. L., T. L. Walunas, and J. A. Bluestone. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:233.
6. Thompson, C. B., and J. P. Allison. 1997. The emerging role of CTLA-4 as an immune attenuator. Immunity 7:445.
7. + T cells in vitro. J. Exp. Med. 183:2247.
8. Green, J. M., P. J. Noel, A. I. Sperling, T. L. Walunas, G. S. Gray, J. A. Bluestone, and C. B. Thompson. 1994. Absence of B7-dependent responses in CD28-deficient mice. Immunity 1:501.
9. + T cells independently of the CD28/B7 and LFA-1/ICAM-1 costimulatory interactions. J. Immunol. 160:3180.
10. + cytotoxic T lymphocytes in the absence of exogenous help. J. Exp. Med. 177:1791.
11. Shahinian, A., K. Pfeffer, K. P. Lee, T. M. Kundig, K. Kishihara, A. Wakeham, K. Kawai, P. S. Ohashi, C. B. Thompson, and T. M. Mak. 1993. Differential T cell costimulatory requirement in CD28-dificient mice. Science 261:609.
12. Kundig, T. M., H. Schorle, M. F. Bachmann, H. Hengartner, R. M. Zinkernagel, and I. Horak. 1993. Immune responses in IL-2 deficient mice. Science 262:1059.
13. Freeman, G. J., V. A. Boussiotis, A. Anumanthan, G. M. Bernstein, X. Y. Ke, P. D. Rennert, G. S. Gray, J. G. Gribbon, and L. M. Nadler. 1995. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 2:523.
14. Schweitzer, A. N., F. Borriello, R. C. Wong, A. K. Abbas, and A. H. Sharpe. 1997. Role of costimulators in T cell differentiation: studies using antigen-presenting cells lacking expression of CD80 and CD86. J. Immunol. 158:2713.
15. Bluestone, J. A. 1995. New perspectives of CD28-B7-mediated T cell costimulation. Immunity 2:555.
16. Kuchroo, V. K., M. P. Das, J. A. Brown, A. M. Ranger, S. S. Zamvil, R. A. Sobel, H. L. Weiner, N. Nabavi, and L. H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:707.
17. Lenschow, D. J., S. C. Ho, H. Sattar, L. Rhee, G. Gray, N. Nabavi, K. C. Herold, and J. A. Bluestone. 1995. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J. Exp. Med. 181:1145.
18. Walunas, T. L., D. J. Lenschow, C. Y. Bakker, P. S. Linsley, G. J. Freeman, J. M. Green, C. B. Thompson, and J. A. Bluestone. 1994. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1:405.
19. Krummel, M. F., and J. P. Allison. 1995. CD28 and CTLA-4 deliver opposing signals which regulate the response of T cells to stimulation. J. Exp. Med. 182: 459.
20. Karandikar, N. J., C. L. Vanderlugt, T. L. Walunas, S. D. Willer, and J. A. Bluestone. 1996. CTLA-4: a negative regulator of autoimmune disease. J. Exp. Med. 184:783.
21. Leach, D. R., M. F. Krummel, and J. P. Allison. 1996. Enhancement of antitumor immunity by CTLA-4 blockade. Science 271:1734.
22. + T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4. J. Immunol. 155:1032.
23. Waterhouse, P., J. M. Penninger, E. Timms, A. Wakeham, A. Shahinian, K. P. Lee, C. B. Thompson, H. Griesser, and M. T. Tak. 1995. Lymphoproliferative disorders with early lethality in mice dificient in CTLA-4. Science 270: 985.
24. Tivol, E. A., F. Borriello, A. N. Schweitzer, W. P. Lynch, J. A. Bluestone, and A. H. Sharpe. 1995. Loss of CTLA-4 leads to massive lymphoproliferative and fetal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3:541.
25. Perez, V. L., L. V. Parijs, A. Biuckians, X. X. Zheng, T. B. Strom, and A. K. Abbas. 1997. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 6:411.
26. Walunas, T. L., and J. A. Bluestone. 1998. CTLA-4 regulates tolerance induction and T cell differentiation in vivo. J. Immunol. 160:3855.
27. Mamalaki, C., J. Elliott, T. Norton, N. Yannoutos, A. R. Townsend, P. Chandler, E. Simpson, and D. Kioussis. 1993. Positive and negative selection in transgenic mice expressing a T cell receptor specific for influenza nucleoprotein and endogenous superantigen. Dev. Immunol. 3:159.
28. Tomonari, K. 1985. T cell receptor expressed on an autoreactive T cell clone, clone 4. I. Induction of various T-receptor functions by anti-T idiotypic antibodies. Cell. Immunol. 96:147.
29. Douek, D. C., K. T. T. Corley, T. Zal, A. Mellor, P. J. Dyson, and D. M. Altmann. 1996. Negative selection by endogenous antigen and superantigen occurs at multiple thymic sites. Int. Immunol. 8:1413.
30. Scott, D. M., I. E. Ehrmann, P. S. Ellis, C. E. Bishop, A. I. Agulnik, E. Simpson, and M. J. Mitchell. 1995. Identification of a mouse male-specific antigen, H-Y. Nature 376:695.
31. Chai, J-G., and R. Lechler. 1997. Immobilized anti-CD3 mAb induces anergy in murine naive and memory CD4 T cells in vitro. Int. Immunol. 7:935.
32. + T cells induces anergy and apoptosis. J. Immunol. 160:3655.
33. + T cells. J. Exp. Med. 185:641.
34. Lezzi, G., K. Karjalainen, and A. Lanzavecchia. 1998. The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity 8:89.
35. + T cells. Proc. Natl. Acad. Sci. USA 93:14736.
36. Nieland, J. D., and A. M. Kruisbeek. 1995. A T cell lymphoma can provide potent co-stimulatory effects to T cells that are not mediated by B7-1, B7-2, CD40, HSA or CD70. Int. Immunol. 7:1827.
37. Walunas, T. L., C. Y. Bakker, and J. A. Bluestone. 1996. CTLA-4 ligation blocks CD28-dependent T cell activation. J. Exp. Med. 183:2541.
38. + T cells by costimulation with B7-2 molecules. J. Immunol. 160:1638.
39. Hayashi, R. J., D. Y. Loh, O. Kanagawa, and F. Wang. 1998. Differences between responses of naive and activated T cells to anergy induction. J. Immunol. 160:33.